BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1524018)

  • 1. Ulcerative colitis.
    Am Pharm; 1992 Aug; NS32(8):27. PubMed ID: 1524018
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesalamine for ulcerative colitis.
    Med Lett Drugs Ther; 1988 May; 30(766):53-4. PubMed ID: 3283508
    [No Abstract]   [Full Text] [Related]  

  • 3. Asacol: mesalazine for ulcerative colitis.
    Drug Ther Bull; 1986 May; 24(10):38-40. PubMed ID: 3709355
    [No Abstract]   [Full Text] [Related]  

  • 4. Five-aminosalicylic acid enemas in treatment of ulcerative colitis.
    Fedotin MS
    Mo Med; 1985 Jun; 82(6):301-3. PubMed ID: 4010664
    [No Abstract]   [Full Text] [Related]  

  • 5. Choosing an oral 5-aminosalicylic acid preparation for ulcerative colitis.
    Drug Ther Bull; 1992 Jun; 30(13):50-2. PubMed ID: 1628539
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-ASA for ulcerative colitis.
    Meyers S; Janowitz HD
    N Engl J Med; 1988 Jun; 318(24):1620-1. PubMed ID: 3287160
    [No Abstract]   [Full Text] [Related]  

  • 7. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW; Gales BJ
    Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity to 5-aminosalicylic acid in patients with ulcerative colitis.
    Niv Y
    Isr J Med Sci; 1987 Nov; 23(11):1161-3. PubMed ID: 3436802
    [No Abstract]   [Full Text] [Related]  

  • 9. [New developments in therapy with 5-aminosalicylic acid preparations in ulcerative colitis and Crohn disease].
    Kruis W
    Z Gastroenterol Verh; 1991 Mar; 26():154-6. PubMed ID: 1714132
    [No Abstract]   [Full Text] [Related]  

  • 10. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
    Feurle GE; Helmstädter V
    Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral asacol in the treatment of mild to moderate ulcerative colitis: the Nashville experience.
    Pruitt RE; Gremillion DE; Herring RW; Bailey AH; Faust TW; Potter M; Long KM
    J Tenn Med Assoc; 1991 May; 84(5):237. PubMed ID: 2067380
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of ulcerative colitis].
    Turunen U; Järvinen HJ
    Duodecim; 1993; 109(2):145-51. PubMed ID: 7912179
    [No Abstract]   [Full Text] [Related]  

  • 13. [Salazosulfapyridine or 5-aminosalicylic acid].
    van Hees PA
    Ned Tijdschr Geneeskd; 1987 May; 131(22):931-4. PubMed ID: 2885762
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ulcerative colitis. Evaluation of a newly developed activity index within the scope of a therapeutic study of mesalazin].
    Maier K; von Gaisberg U; Kraus B; Kimmig JM; Tippmann P; Gerhard F; Lepiorz P
    Fortschr Med; 1987 Jan; 105(2):61, 65-6, 69. PubMed ID: 3557255
    [No Abstract]   [Full Text] [Related]  

  • 15. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
    Malchow H
    Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity].
    Loizeau E
    Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aminosalicylates in the treatment of chronic inflammatory bowel diseases].
    Hartmann F; Plauth M
    Internist (Berl); 1990 Nov; 31(11):702-6. PubMed ID: 2289856
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission.
    Eliakim R; Wengrower D; Ligumsky M; Rachmilewitz D
    Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895
    [No Abstract]   [Full Text] [Related]  

  • 20. [5-aminosalicylic acid treatment of ulcerative colitis during the acute phase in patients resistant or intolerant to salazopyrine].
    Cappello M; Puleo A; Calabrese A; Cipolla C; Orlando A; Gatto G; Oliva L; Cottone M
    Recenti Prog Med; 1987 Feb; 78(2):76-8. PubMed ID: 2884701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.